pCMV_BE4max
Mammalian expression plasmid for the BE4max cytosine base editor: a CMV promoter drives BE4max (bpNLS, APOBEC1 deaminase, XTEN linker, Cas9 D10A nickase, two UGI domains, bpNLS), terminated by a bGH polyadenylation signal, on an ampicillin-resistance backbone. Deposited as Addgene #112093.
Characteristics
8,961 bp circular plasmid. The BE4max coding sequence is 5,562 bp including its stop codon; the Cas9 module carries the D10A nickase mutation and the editor carries a bipartite nuclear localization signal at each end.
Applications
Expressing the BE4max cytosine base editor (rAPOBEC1-based, Cas9 D10A nickase, two UGI domains) by transfection in mammalian cells. Other groups used Addgene #112093 as follows. (1) As the rA1-CBE in HEK293T cells, cotransfected with sgRNA and anti-deaminase proteins (Ade) at a 1:1:1 plasmid ratio; the rA1-CBE was not inhibited by the Ades tested (Nat Commun 2022, 10.1038/s41467-022-28300-0). (2) As the template for BE4max mRNA: the CMV-driven coding sequence, which carries a T7 promoter, was subcloned with a WPRE and poly(A), linearized and transcribed in vitro; the mRNA was electroporated into human primary T cells and CD34+ hematopoietic stem and progenitor cells (HSPCs) with a B2M-targeting gRNA. BE4max produced 80-90% B2M-knockout cells in primary T cells, and in HSPCs it caused excess indels and reduced long-term engraftment compared with ABE8.20-m (Nat Biotechnol 2023, 10.1038/s41587-023-01915-4). (3) As the backbone of p2T-CMV-BE4max-BlastR, a modified BE4max plasmid with a blasticidin resistance cassette flanked by Tol2 transposon sequences, which expressed BE4 variants with SpCas9-PAM variants in HEK293T library cells (Nat Biotechnol 2020, 10.1038/s41587-020-0412-8). (4) As a comparator purchased from Addgene: in a GFP-disruption reporter assay BE4max showed no activity, while the MEGA-4 editor of that study did (Nucleic Acids Res 2023, 10.1093/nar/gkad1118). A fifth paper (Nat Commun 2022, 10.1038/s41467-022-30514-1) compares its NBE4max architecture (UGI moved to the N-terminus of rAPOBEC1) with BE4max and reports similar editing efficiencies; it does not state the plasmid used.
Payload18 features
in a 8,961 bp deposit · 12 features outside the design
Sequence6,834 bp
Sign in to view the full sequence.
Sign inReferences
- 1.Koblan et al. (2018). Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction. Nat Biotechnol — Koblan 2018 BE4max
